Suppr超能文献

痔切除术后填塞敷料与不填塞敷料的比较:一项随机对照试验的研究方案

Tamponade dressings versus no tamponade after hemorrhoidectomy: study protocol for a randomized controlled trial.

作者信息

Langenbach Mike Ralf, Seidel Dörthe

机构信息

Klinik für Allgemein-/Viszeralchirurgie und Koloproktologie, Helios St. Elisabeth Klinik, Josefstr. 3, 46045, Oberhausen, Germany.

Institut für Forschung in der Operativen Medizin (IFOM), Universität Witten/Herdecke, Ostmerheimerstraße 200 Haus 38, 51109, Köln, Germany.

出版信息

Trials. 2019 Apr 2;20(1):188. doi: 10.1186/s13063-019-3280-0.

Abstract

BACKGROUND

Symptomatic hemorrhoids are one of the most common anorectal disorders. Many surgeons use tamponades after open hemorrhoidectomy to manage postoperative bleeding. The question of whether a tamponade is necessary and beneficial after hemorrhoidectomy has not yet been conclusively answered. A previously conducted single-center pilot trial included 100 patients after Milligan-Morgan hemorrhoidectomy. The data indicated that insertion of an anal tamponade after hemorrhoidectomy does not reduce postoperative bleeding but causes significantly more pain. The findings of this pilot trial are now to be verified by means of a multicenter randomized clinical study called NoTamp.

METHODS

We plan to include 953 patients after Milligan-Morgan or Parks hemorrhoidectomy in the NoTamp study. The aim is to demonstrate that using no tamponade dressing after open hemorrhoidectomy is not inferior to using tamponades with respect to postoperative bleeding, and that the patients report less pain. Primary endpoints of the trial are the maximum postoperative pain within 48 h and the incidence of severe postoperative bleeding that requires surgical revision within 7 days after the surgical procedure. Secondary endpoints of the study are the use of analgesics in the postoperative course, the lowest hemoglobin documented within 7 days, quality of life and patient satisfaction. Safety analysis includes all adverse and serious adverse events in relation to the study treatment. Further information can be found in the registration at the German Registry of Clinical Studies (DRKS00011590) and on the study webpage ( https://notamp.de/en-GB/trial/main/setLocale/en_GB/ ). The study is financed by the HELIOS research funding.

DISCUSSION

The study received full ethics committee approval. The first patient was enrolled on 3 May 2017. This trial will finally answer the question whether the insertion of a tamponade after open hemorrhoidectomy is necessary and beneficial.

TRIAL REGISTRATION

German Clinical Trials Register (Deutsches Register Klinischer Studien (DRKS), DRKS00011590 . Registered on 12 April 2017.

摘要

背景

有症状的痔疮是最常见的肛肠疾病之一。许多外科医生在开放性痔切除术后使用填塞物来处理术后出血。痔切除术后填塞物是否必要且有益这一问题尚未得到最终解答。之前进行的一项单中心试点试验纳入了100例接受Milligan-Morgan痔切除术后的患者。数据表明,痔切除术后插入肛门填塞物并不能减少术后出血,反而会导致更多疼痛。现在将通过一项名为NoTamp的多中心随机临床研究来验证该试点试验的结果。

方法

我们计划在NoTamp研究中纳入953例接受Milligan-Morgan或Parks痔切除术后的患者。目的是证明开放性痔切除术后不使用填塞敷料在术后出血方面不劣于使用填塞物,且患者报告的疼痛更少。该试验的主要终点是术后48小时内的最大疼痛程度以及手术后7天内需要手术修正的严重术后出血发生率。该研究的次要终点是术后过程中镇痛药的使用情况、7天内记录的最低血红蛋白水平、生活质量和患者满意度。安全性分析包括与研究治疗相关的所有不良和严重不良事件。更多信息可在德国临床研究注册中心(DRKS00011590)的注册信息以及研究网页(https://notamp.de/en-GB/trial/main/setLocale/en_GB/)上找到。该研究由HELIOS研究基金资助。

讨论

该研究获得了伦理委员会的全面批准。首例患者于2017年5月3日入组。这项试验将最终回答开放性痔切除术后插入填塞物是否必要且有益这一问题。

试验注册

德国临床试验注册中心(Deutsches Register Klinischer Studien (DRKS),DRKS00011590。于2017年4月12日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/149a/6444871/c975f9fe6c15/13063_2019_3280_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验